Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 4, 2021
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
Salim Syed Maintained (BBIO) at Strong Buy with Increased Target to $86 on, Mar 4th, 2021
Salim Syed of Mizuho, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $56 to $86 on, Mar 4th, 2021.
Salim has made no other calls on BBIO in the last 4 months.
There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Salim's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Salim
- Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $83 on, Tuesday, February 9th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $44 on, Friday, December 4th, 2020
